Solventum
$87.85Change from previous close: +0.09%Absolute change: +$0.08
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $15.07B
- Enterprise value
- $19.83B
- P/E (trailing 12 months)
- 10.9
- Forward P/E
- 12.2
- PEG
- 1.22
- Price/book
- 3.14
- Price/sales
- 1.81
- EV/EBITDA
- 17.4
- EV/revenue
- 2.39
Profitability and growth
- Gross margin
- 54.8%
- Operating margin
- 9.8%
- Net margin
- 17.3%
- ROE
- 34.0%
- ROA
- 2.7%
- Revenue growth (year over year)
- 2.2%
- Earnings growth (year over year)
- 3.9%
Financial health
- Total cash
- $403M
- Total debt
- $5.3B
- Debt/equity
- 1.10
- Current ratio
- 1.02
- Quick ratio
- 0.50
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $93.92
- Median price target
- $95.00
- High price target
- $113.00
- Low price target
- $70.00
- Analysts with a price target
- 13
- Consensus
- Buy
- Forward EPS
- $7.23
- EPS estimate, current year
- $7.14
Shares and trading
- Beta
- 0.69
- Average volume
- 1.03M
- Shares outstanding
- 170.22M
- Float
- 144.09M
- Institutional ownership
- 75.9%
- Insider ownership
- 15.3%
- Short interest (% of float)
- 3.4%
- Short ratio (days)
- 5.26